跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVERAM levetiracetam 500 mg/5 mL concentrated injection for IV infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
LEVERAM levetiracetam 500 mg/5 mL concentrated injection for IV infusion vial
Approved
STANDARD
LEVERAM levetiracetam 500 mg/5 mL concentrated injection for IV infusion vial
Micro Labs Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
41eec8acc5389e81
Company
Micro Labs Pty Ltd
Type
Standard
Approval Details
Approval Id
41eec8acc5389e81
Product Name
LEVERAM levetiracetam 500 mg/5 mL concentrated injection for IV infusion vial
Artg Id
397980
Artg Name
LEVERAM levetiracetam 500 mg/5 mL concentrated injection for IV infusion vial
Sponsor
Micro Labs Pty Ltd
Company Detail Path
/organization/micro-labs-pty-ltd
Artg Date
2023-08-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
41eec8acc5389e81
Type
Standard
Back to TGA Approvals